SoluScale solves one of the biggest challenges in cell therapy manufacturing: scaling from process development to clinical development and commercial manufacture.
By using the same consumable and process throughout, SoluScale eliminates the need to re-platform. This reduces time, cost and risk enabling cell therapies to reach more patients.
increase in
throughput vs legacy processes
full scale development runs
transduction efficiencies
unique human
primary T cells
donors
Based on internal modelling/comparison with conventional manufacturing platforms.
At the heart of the platform is the SoluScale Cell Chamber (SCC).
You can use the SCC manually during process development, then use the same consumable within our compact automated manufacturing unit (AMU). The AMU is a GMP-ready platform that scales with your needs.
There is no need to change the process because the chamber stays the same.
Built for superior cell viability and yields
A compact footprint reduces space and facility investment.
Provides greater process control, consistency and confidence.
The same process supports production from one to thousands of doses.
With greater confidence and predictability from the outset, capital investment can be deferred until it is necessary.
SoluScale gives you a flexible, modular path to commercial manufacturing tailoring your build to satisfy patient demand.
Get in touch, we're here to help
